Description
HGH 176-191, a synthetic peptide derived from the C-terminal of human growth hormone, exhibits diverse biological activities. In the context of obesity management, it demonstrates efficacy in reducing fat accumulation and promoting lipolysis, thereby supporting healthy weight reduction. Regarding blood glucose regulation, it helps maintain blood glucose homeostasis, offering auxiliary support for individuals with diabetes. This multifunctional peptide segment reveals significant potential applications in both obesity and blood glucose management. Its ability to influence metabolic processes related to fat and glucose metabolism highlights its importance in addressing metabolic disorders.
The peptide will be provided as lyophilized powder to ensure maximum stability.
